Systemic oxidative stress in patients with pulmonary sarcoidosis

Pulmonary Pharmacology and Therapeutics

Volumn 22, Issue 6, 2009, Pages 603-607

  Koutsokera, Angela ^a   Papaioannou, Andriana I ^a   Malli, Foteini ^a   Kiropoulos, Theodoros S ^a   Katsabeki, Alexandra ^a   Kerenidi, Theodora ^a   Gourgoulianis, Konstantinos I ^a   Daniil, Zoe D ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Corticosteroids; Oxidative stress; Sarcoidosis

Indexed keywords

CORTICOSTEROID; HYDROPEROXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; MALE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; SARCOIDOSIS; SPECTROPHOTOMETRY;

ADRENAL CORTEX HORMONES; AGED; DYSPNEA; FEMALE; HUMANS; HYDROGEN PEROXIDE; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY;

EID: 71249114708     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2009.09.002     Document Type: Article

References (23)

1. Statement on sarcoidosis. Joint statement of the American thoracic society (ATS), the European respiratory society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 (1999) 736-755
2. Sharma O.P. Markers of sarcoidosis activity. Chest 90 (1986) 471-473
3. Bowler R.P., and Crapo J.D. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 110 (2002) 349-356
4. Chow C.W., Herrera Abreu M.T., Suzuki T., and Downey G.P. Oxidative stress and acute lung injury. Am J Respir Cell Mol Biol 29 (2003) 427-431
5. Daniil Z.D., Papageorgiou E., Koutsokera A., Kostikas K., Kiropoulos T., Papaioannou A.I., et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther 21 (2008) 26-31
6. Cassatella M.A., Berton G., Agostini C., Zambello R., Trentin L., Cipriani A., et al. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis. Immunology 66 (1989) 451-458
7. Nielsen H., Frederiksen J., Sherson D., and Milman N. Comparison of alveolar macrophage and blood monocyte oxidative burst response in pulmonary sarcoidosis. Apmis 98 (1990) 401-406
8. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A., et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 158 (1998) 1524-1527
9. Psathakis K., Papatheodorou G., Plataki M., Panagou P., Loukides S., Siafakas N.M., et al. 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 125 (2004) 1005-1011
10. Iamele L., Fiocchi R., and Vernocchi A. Evaluation of an automated spectrophotometric assay for reactive oxygen metabolites in serum. Clin Chem Lab Med 40 (2002) 673-676
11. Cornelli U., Terranova R., Luca S., Cornelli M., and Alberti A. Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr 131 (2001) 3208-3211
12. Harsem N.K., Braekke K., and Staff A.C. Augmented oxidative stress as well as antioxidant capacity in maternal circulation in preeclampsia. Eur J Obstet Gynecol Reprod Biol 128 (2006) 209-215
13. Baughman R.P., Lower E.E., Pierson G., and Strohofer S. Spontaneous hydrogen peroxide release from alveolar macrophages of patients with active sarcoidosis: comparison with cigarette smokers. J Lab Clin Med 111 (1988) 399-404
14. Fels A.O., Nathan C.F., and Cohn Z.A. Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3. J Clin Invest 80 (1987) 381-386
15. Calhoun W.J., and Salisbury S.M. Heterogeneity in cell recovery and superoxide production in buoyant, density-defined subpopulations of human alveolar macrophages from healthy volunteers and sarcoidosis patients. J Lab Clin Med 114 (1989) 682-690
16. Schaberg T., Rau M., Stephan H., and Lode H. Increased number of alveolar macrophages expressing surface molecules of the CD11/CD18 family in sarcoidosis and idiopathic pulmonary fibrosis is related to the production of superoxide anions by these cells. Am Rev Respir Dis 147 (1993) 1507-1513
17. Moller D.R. Potential etiologic agents in sarcoidosis. Proc Am Thorac Soc 4 (2007) 465-468
18. Ma Y., Gal A., and Koss M.N. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 24 (2007) 150-161
19. Muller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12 (1998) 716-738
20. Grunewald J., and Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 4 (2007) 461-464
21. Haddad J.J. Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology. Respir Res 3 (2002) 26
22. Barnes P.J., Adcock I.M., and Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25 (2005) 552-563
23. Turner-Warwick M., McAllister W., Lawrence R., Britten A., and Haslam P.L. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management?. Thorax 41 (1986) 903-913